Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer (LucaVax)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by Kael-GemVax Co., Ltd..
Recruitment status was  Not yet recruiting
Quintiles, Inc.
Information provided by (Responsible Party):
Kael-GemVax Co., Ltd. Identifier:
First received: April 13, 2012
Last updated: April 18, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: May 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)